the full WP markdown article
Eli Lilly Crushes Q4 2025 Earnings With Massive Zepbound Boost
Eli Lilly just dropped their Q4 2025 earnings, and the numbers are staggering – revenue way above expectations thanks to Zepbound and Mounjaro. But what does the strong 2026 guidance really mean for investors, and is the GLP-1 boom here to stay? ...
Financial market analysis from 04/02/2026. Market conditions may have changed since publication.
❝
I will tell you how to become rich. Close the doors. Be fearful when others are greedy. Be greedy when others are fearful.
— Warren Buffett
Author
Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.
Previous
AMD Stock Drops 9% Post-Earnings: What Really Happened
Next
Sheryl Sandberg Backs AI Workplace Startup Slashwork
Related Articles
Market News
Unveiling the Funding Behind Social Unrest Networks
Ever wondered who’s funding the chaos in our cities? A new report uncovers a web of NGOs fueling unrest with big money. Dive in to see how it works...
Oct 9, 2025
5 min read
Crypto
Dogecoin Plunges Below Key Supports in Crypto Slump
Dogecoin just shattered key supports, diving deeper into the red as the crypto world reels. With Bitcoin and Ethereum dragging it down, is this the start of a bigger slide—or a hidden buying chance? Technicals scream caution, but savvy traders might see...
Dec 1, 2025
11 min read
Smart Money
China’s Trade Shift: Impact On Global Markets
China's bold trade official shake-up could reshape global markets. What does this mean for your investments? Click to find out...
Apr 16, 2025
5 min read